Search Result "LDL heterogeneity"
Rapid and Simple Profiling of Lipoproteins by Polyacrylamide-Gel Disc Electrophoresis to Determine the Heterogeneity of Low-Density Lipoproteins (LDLs) Including Small, Dense LDL
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 4 Issue: 1 Year: 2009 Page: 31-36
Author(s): Takanari Nakano, Ikuo Inoue, Makoto Seo, Seiichiro Takahashi, Takuya Awata, Tsugikazu Komoda, Shigehiro Katayama
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5 Issue: 2 Year: 2010 Page: 143-152
Author(s): Ikuo Inoue, Takuya Awata, Shigehiro Katayama
An Update on the Role of the Quality of LDL in Cardiovascular Risk:The Contribution of the Universities of Palermo and Zurich
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 2 Issue: 2 Year: 2007 Page: 85-88
Author(s): Manfredi Rizzo, Kaspar Berneis
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 6 Year: 2010 Page: 820-830
Author(s): Matilda Florentin, Alexadros D. Tselepis, Moses S. Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos N. Liberopoulos
Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3858-3868
Author(s): Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis, Maciej Banach
Role of Curcumin in Modulating Plasma PON1 Arylesterase Activity and Susceptibility to LDL Oxidation in Oxidatively Challenged Wistar Rats
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 4 Year: 2015 Page: 319-323
Author(s): Prabhakar Singh,Syed Ibrahim Rizvi
Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5865-5872
Author(s): Howar S. Kruth